お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
967883

米国の心臓手術・人工心臓弁市場(2020年~2026年)COVID-19の影響:MedSuite

Cardiac Surgery and Heart Valve Device Market Report Suite with COVID Impact - United States - 2020-2026 - MedSuite

出版日: | 発行: iData Research Inc. | ページ情報: 英文 618 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

米国の心臓手術・人工心臓弁市場(2020年~2026年)COVID-19の影響:MedSuite
出版日: 2020年10月08日
発行: iData Research Inc.
ページ情報: 英文 618 Pages
納期: 即日から翌営業日
担当者のコメント
当サービス(MedSuite)は、セグメント別(MedCore)でご注文可能です。まずはサンプルを送付させていただきますので、ご希望のセグメントをお知らせください。セグメント:「組織心臓弁装置」「人工心臓弁装置」「弁輪形成術修復装置」「経カテーテル僧帽弁修復装置」「経カテーテル心臓弁置換装置」「脳塞栓保護装置」「バルーン弁形成術装置」、他。セグメントの詳細は目次の製品ポートフォリオをご覧下さい。
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の心臓手術・人工心臓弁の市場規模は、2019年に72億米ドルとなりました。同市場は、予測期間中に7.7%のCAGRで成長し、121億米ドルに達すると予測されています。心臓手術市場の主な成長要因には、患者人口が挙げられます。米国では約120万人が石灰化したり、大動脈弁が損傷したりしており、この状態は一般的に、他にもいくつかの合併症を持つ患者に見られるため、開腹手術や侵襲的手術の候補にはなりません。

当レポートは、米国の心臓手術・人工心臓弁市場について調査しており、市場の動向や予測、COVID-19の影響、成長および抑制要因、製品別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

図のリスト

チャートのリスト

エグゼクティブサマリー

米国の市場概要

競合分析

動向

市場の進展

手術件数

調査対象の手術コード

市場範囲

主なレポートの更新

バージョン履歴

調査手法

疾患の概要

  • 基本的な解剖学
  • 病気の治療と診断
    • 冠動脈疾患
    • 心筋梗塞
    • 狭心症
    • 心臓弁膜症
    • うっ血性心不全
    • 大動脈弁狭窄症
    • 変性/機能性僧帽弁逆流
  • 患者の人口統計
    • 一般的な統計

製品評価

  • イントロダクション
  • 製品ポートフォリオ
    • 組織心臓弁装置
    • 人工心臓弁装置
    • 弁輪形成術修復装置
    • 経カテーテル僧帽弁修復装置
    • 経カテーテル心臓弁置換装置
    • 脳塞栓保護装置
    • バルーン弁形成術装置
    • オンポンプ冠状動脈バイパス装置
    • オフポンプ冠状動脈バイパス装置
    • 自動輸血装置
    • 内視鏡血管採取装置
    • 吻合補助装置
    • 経心筋血行再建装置
    • 心室補助装置
    • 大動脈内バルーンポンプ装置
    • 人工心臓置換装置
    • リモート血行動態モニタリングシステムデバイス
    • 卵円孔開存装置
    • 動脈管開存症の閉鎖装置
    • 心房および心室中隔欠損装置
    • 左心耳閉鎖装置
    • 成形済みガイドワイヤー
  • 規制上の問題とリコール
  • 臨床試験
    • Abbott
    • CryoLife
    • Edwards LifeSciences
    • Medtronic

COVID-19の影響

  • イントロダクション
  • マルチシナリオ分析

米国の市場概要

  • イントロダクション
  • 市場概要
  • セグメント別の動向分析
  • 成長要因と抑制要因
    • 市場の成長要因
    • 市場の抑制要因
  • 競合市場シェア分析
  • 合併と買収
  • 企業プロファイル
    • Abbott
    • Abiomed
    • AtriCure
    • Boston Scientific
    • CryoLife
    • Edwards LifeSciences
    • LivaNova
    • Getinge
    • Medtronic
    • Teleflex
    • Terumo
  • SWOT分析
    • Abbott
    • Abiomed
    • AtriCure
    • Boston Scientific
    • CryoLife
    • Edwards LifeSciences
    • LivaNova
    • Getinge
    • Medtronic
    • Teleflex
    • Terumo

手術件数

  • イントロダクション
  • 心臓外科および心臓弁
  • 外科的心臓弁置換
  • 弁輪形成術の修復
  • 経カテーテル僧帽弁修復
  • 経カテーテル心臓弁置換
  • 大動脈弁形成術
  • CABG
  • 経心筋血行再建
  • 心室補助装置
  • 大動脈内バルーンカウンターパルセーション
  • 心臓移植
  • リモート血行動態モニタリングデバイスの埋め込み
  • 卵円孔の閉鎖
  • 動脈管開存症の閉鎖
  • 中隔欠損閉鎖
  • 左心耳閉鎖

組織心臓弁市場

  • イントロダクション
  • 市場概要
    • デバイスタイプ別
    • 組織タイプ別
  • 市場分析と予測
    • 組織心臓弁総市場
    • デバイスタイプ別
    • 組織タイプ別
  • 成長要因と抑制要因
    • 市場の成長要因
    • 市場の抑制要因
  • 競合市場シェア分析

人工心臓弁市場

弁輪形成術修復装置市場

経カテーテル僧帽弁修復装置市場

経カテーテル心臓弁置換装置市場

脳塞栓保護装置市場

図表

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026
  • Chart 1 2: Cardiac Surgery and Heart Valve Device Market Overview, U.S., 2019 & 2026
  • Chart 4 1: Multi-Scenario Cardiac Surgery and Heart Valve Device Market, U.S., 2016 - 2026
  • Chart 5 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026
  • Chart 5 2: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2019
  • Chart 5 3: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2026
  • Chart 5 4: Growth Rates by Segment, Cardiac Surgery and Heart Valve Device Market, U.S., 2016 - 2026
  • Chart 5 5: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2019
  • Chart 6 1: Cardiac Surgery and Heart Valve Procedures, U.S., 2016 - 2026
  • Chart 6 2: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 3: Tissue Heart Valve Procedures by Valve Type, U.S., 2016 - 2026
  • Chart 6 4: Tissue Heart Valve Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 5: Tissue Heart Valve Procedures by Tissue Type, U.S., 2016 - 2026
  • Chart 6 6: Mechanical Heart Valve Procedures by Valve Type, U.S., 2016 - 2026
  • Chart 6 7: Mechanical Heart Valve Replacement Procedures by Tissue Type, U.S., 2016 - 2026
  • Chart 6 8: Annuloplasty Repair Procedures by Valve Type, U.S., 2016 - 2026
  • Chart 6 9: Annuloplasty Repair Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 10: Transcatheter Mitral Valve Repair Procedures, U.S., 2016 - 2026
  • Chart 6 11: Transcatheter Mitral Valve Repair Procedures, U.S., 2016 - 202
  • Chart 6 12: Transcatheter Heart Valve Replacement Procedures, U.S., 2016 - 2026
  • Chart 6 13: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2016 - 2026
  • Chart 6 14: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2016 - 2026
  • Chart 6 15: Transcatheter Aortic Valve Replacement Procedures by Embolic Protection, U.S., 2016 - 2026
  • Chart 6 16: Transcatheter Aortic Heart Valve Replacement Procedures by Therapy, U.S., 2016 - 2026
  • Chart 6 17: Transcatheter Aortic Heart Valve Replacement Procedures by Location, U.S., 2016 - 2026
  • Chart 6 18: Balloon Valvuloplasty Procedures, U.S., 2016 - 2026
  • Chart 6 19: CABG Procedures by Support Type, U.S., 2016 - 2026
  • Chart 6 20: CABG Vessel Harvesting Procedures by Type, U.S., 2016 - 2026
  • Chart 6 21: CABG Procedures by Suture Type, U.S., 2016 - 2026
  • Chart 6 22: CABG Procedures by Approach, U.S., 2016 - 2026
  • Chart 6 23: Transmyocardial Revascularization Procedures, U.S., 2016 - 2026
  • Chart 6 24: Ventricular Assist Device Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 25: Percutaneous Ventricular Assist Procedures by Heart Side, U.S., 2016 - 2026
  • Chart 6 26: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2016 - 2026
  • Chart 6 27: Implantable Ventricular Assist Procedures by Indication, U.S., 2016 - 2026
  • Chart 6 28: Implantable Ventricular Assist Procedures by Area, U.S., 2016 - 2026
  • Chart 6 29: External Ventricular Assist Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 30: Intra-Aortic Balloon Counterpulsation Procedures by Setting, U.S., 2016 - 2026
  • Chart 6 31: Intra-Aortic Balloon Counterpulsation Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 32: Heart Transplant Procedures by Type, U.S., 2016 - 2026
  • Chart 6 33: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2016 - 2026
  • Chart 6 34: Patent Foramen Ovale Closure Procedures, U.S., 2016 - 2026
  • Chart 6 35: Patent Ductus Arteriosus Closure Procedures, U.S., 2016 - 2026
  • Chart 6 36: Septal Defect Closure Procedures by Type, U.S., 2016 - 2026
  • Chart 6 37: Left Atrial Appendage Closure Procedures by Type, U.S., 2016 - 2026
  • Chart 6 38: Epicardial Device Procedures by Device Type, U.S., 2016 - 2026
  • Chart 6 39: Epicardial Clip Device Procedures by Approach, U.S., 2016 - 2026
  • Chart 7 1: Tissue Heart Valve Market by Device Type, U.S., 2016 - 2026
  • Chart 7 2: Tissue Heart Valve Market Breakdown by Device Type, U.S., 2019
  • Chart 7 3: Tissue Heart Valve Market Breakdown by Device Type, U.S., 2026
  • Chart 7 4: Tissue Heart Valve Market by Tissue Type, U.S., 2016 - 2026
  • Chart 7 5: Tissue Heart Valve Market Breakdown by Tissue Type, U.S., 2019
  • Chart 7 6: Tissue Heart Valve Market Breakdown by Tissue Type, U.S., 2026
  • Chart 7 7: Total Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 8: Stented Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 9: Sutureless/Rapid Deployment Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 10: Stentless Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 11: Xenograft Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 12: Allograft Tissue Heart Valve Market, U.S., 2016 - 2026
  • Chart 7 13: Leading Competitors, Tissue Heart Valve Market, U.S., 2019
  • Chart 8 1: Mechanical Heart Valve Market by Segment, U.S., 2016 - 2026
  • Chart 8 2: Mechanical Heart Valve Market Breakdown, U.S., 2019
  • Chart 8 3: Mechanical Heart Valve Market Breakdown, U.S., 2026
  • Chart 8 4: Total Mechanical Heart Valve Market, U.S., 2016 - 2026
  • Chart 8 5: Mechanical Heart Valve without Conduit Market, U.S., 2016 - 2026
  • Chart 8 6: Mechanical Heart Valve with Conduit Market, U.S., 2016 - 2026
  • Chart 8 7: Leading Competitors, Mechanical Heart Valve Market, U.S., 2019
  • Chart 9 1: Annuloplasty Repair Device Market by Segment, U.S., 2016 - 2026
  • Chart 9 2: Annuloplasty Repair Device Market Breakdown, U.S., 2019
  • Chart 9 3: Annuloplasty Repair Device Market Breakdown, U.S., 2026
  • Chart 9 4: Total Annuloplasty Repair Device Market, U.S., 2016 - 2026
  • Chart 9 5: Ring Device Market, U.S., 2016 - 2026
  • Chart 9 6: Band Device Market, U.S., 2016 - 2026
  • Chart 9 7: Leading Competitors, Annuloplasty Repair Device Market, U.S., 2019
  • Chart 10 1: Transcatheter Mitral Valve Repair Device Market, U.S., 2016 - 2026
  • Chart 10 2: Leading Competitors, Cardiac Surgery and Heart Valve Device Market , U.S., 2019
  • Chart 11 1: Transcatheter Heart Valve Replacement Device Market by Segment, U.S., 2016 - 2026
  • Chart 11 2: Transcatheter Heart Valve Replacement Device Market Breakdown, U.S., 2019
  • Chart 11 3: Transcatheter Heart Valve Replacement Device Market Breakdown, U.S., 2026
  • Chart 11 4: Total Transcatheter Heart Valve Replacement Device Market, U.S., 2016 - 2026
  • Chart 11 5: Transcatheter Aortic Valve Replacement Device Market, U.S., 2016 - 2026
  • Chart 11 6: Transcatheter Pulmonary Valve Replacement Device Market, U.S., 2016 - 2026
  • Chart 11 7: Leading Competitors, Transcatheter Heart Valve Replacement Device Market, U.S., 2019
  • Chart 12 1: Cerebral Embolic Protection Device Market, U.S., 2016 - 2026
  • Chart 12 2: Leading Competitors, Cerebral Embolic Protection Device Market, U.S., 2019
  • Chart 13 1: Balloon Valvuloplasty Market by Segment, U.S., 2016 - 2026
  • Chart 13 2: Balloon Valvuloplasty Market Breakdown, U.S., 2019
  • Chart 13 3: Balloon Valvuloplasty Market Breakdown, U.S., 2026
  • Chart 13 4: Total Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Chart 13 5: Aortic Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Chart 13 6: Mitral Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Chart 13 7: Pulmonary Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Chart 13 8: Hybrid Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Chart 13 9: Leading Competitors, Balloon Valvuloplasty Market, U.S., 2019
  • Chart 14 1: On-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2016 - 2026
  • Chart 14 2: On-Pump Coronary Artery Bypass Device Market Breakdown, U.S., 2019
  • Chart 14 3: On-Pump Coronary Artery Bypass Device Market Breakdown, U.S., 2026
  • Chart 14 4: ONCAB Disposables Market, U.S., 2016 - 2026
  • Chart 14 5: Perfusion System Market, U.S., 2016 - 2026
  • Chart 14 6: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Chart 15 1: Off-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2016 - 2026
  • Chart 15 2: Off-Pump Coronary Artery Bypass Device Market Breakdown, U.S., 2019
  • Chart 15 3: Off-Pump Coronary Artery Bypass Device Market Breakdown, U.S., 2026
  • Chart 15 4: Stabilizer Device Market, U.S., 2016 - 2026
  • Chart 15 5: Positioner Device Market, U.S., 2016 - 2026
  • Chart 15 6: OPCAB Accessories Market, U.S., 2016 - 2026
  • Chart 15 7: Blower/Mister Market, U.S., 2016 - 2026
  • Chart 15 8: Intracoronary Shunt Market, U.S., 2016 - 2026
  • Chart 15 9: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Chart 16 1: Autotransfusion Device Market by Segment, U.S., 2016 - 2026
  • Chart 16 2: Autotransfusion Device Market Breakdown, U.S., 2019
  • Chart 16 3: Autotransfusion Device Market Breakdown, U.S., 2026
  • Chart 16 4: Autotransfusion Machine Market, U.S., 2016 - 2026
  • Chart 16 5: Autotransfusion Install Base by Agreement, U.S., 2016 - 2026
  • Chart 16 6: Autotransfusion Disposables Market, U.S., 2016 - 2026
  • Chart 16 7: Leading Competitors, Autotransfusion Device Market, U.S., 2019
  • Chart 17 1: Endoscopic Vessel Harvesting Device Market, U.S., 2016 - 2026
  • Chart 17 2: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2019
  • Chart 18 1: Anastomosis Assist Device Market by Segment, U.S., 2016 - 2026
  • Chart 18 2: Anastomosis Assist Device Market Breakdown, U.S., 2019
  • Chart 18 3: Anastomosis Assist Device Market Breakdown, U.S., 2026
  • Chart 18 4: Total Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Chart 18 5: Proximal Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Chart 18 6: Distal Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Chart 18 7: Leading Competitors, Anastomosis Assist Device Market, U.S., 2019
  • Chart 19 1: Transmyocardial Revascularization Device Market by Segment, U.S., 2016 - 2026
  • Chart 19 2: Transmyocardial Revascularization Device Market Breakdown, U.S., 2019
  • Chart 19 3: Transmyocardial Revascularization Device Market Breakdown, U.S., 2026
  • Chart 19 4: Single-Use Fiber-Optic Handpiece Market, U.S., 2016 - 2026
  • Chart 19 5: TMR Laser Console Market by Segment, U.S., 2016 - 2026
  • Chart 19 6: TMR Laser Console Device Market, U.S., 2016 - 2026
  • Chart 19 7: TMR Laser Console Service Market, U.S., 2016 - 2026
  • Chart 19 8: Leading Competitors, Transmyocardial Revascularization Device Market, U.S., 2019
  • Chart 20 1: Ventricular Assist Device Market by Segment, U.S., 2016 - 2026
  • Chart 20 2: Ventricular Assist Device Market Breakdown, U.S., 2019
  • Chart 20 3: Ventricular Assist Device Market Breakdown, U.S., 2026
  • Chart 20 4: Total Ventricular Assist Device Market, U.S., 2016 - 2026
  • Chart 20 5: Percutaneous VAD Market by Segment, U.S., 2016 - 2026
  • Chart 20 6: Left Heart pVAD Market, U.S., 2016 - 2026
  • Chart 20 7: Right Heart pVAD Market, U.S., 2016 - 2026
  • Chart 20 8: Implantable VAD Market, U.S., 2016 - 2026
  • Chart 20 9: External VAD Market by Segment, U.S., 2016 - 2026
  • Chart 20 10: Short-Term External VAD Market, U.S., 2016 - 2026
  • Chart 20 11: Long-Term External VAD Market, U.S., 2016 - 2026
  • Chart 20 12: Implantable Ventricular Assist Device Market Units by Indication, U.S., 2016 - 2026
  • Chart 20 13: Leading Competitors, Ventricular Assist Device Market, U.S., 2019
  • Chart 21 1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2016 - 2026
  • Chart 21 2: Intra-Aortic Balloon Pump Market Breakdown, U.S., 2019
  • Chart 21 3: Intra-Aortic Balloon Pump Market Breakdown, U.S., 2026
  • Chart 21 4: Intra-Aortic Balloon (IABP) Catheter Market by Segment, U.S., 2016 - 2026
  • Chart 21 5: Conventional Intra-Aortic Balloon (IABP) Catheter, U.S., 2016 - 2026
  • Chart 21 6: Fiber-Optic Intra-Aortic Balloon (IABP) Catheter, U.S., 2016 - 2026
  • Chart 21 7: Intra-Aortic Balloon Pump (IABP) Console Market, U.S., 2016 - 2026
  • Chart 21 8: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2019
  • Chart 22 1: Artificial Heart Replacement Device Market, U.S., 2016 - 2026
  • Chart 22 2: Leading Competitors, Temporary Artificial Heart Replacement Device Market, U.S., 2019
  • Chart 23 1: Remote Hemodynamic Monitoring System Market, U.S., 2016 - 2026
  • Chart 23 2: Leading Competitors, Remote Hemodynamic Monitoring System Market, U.S., 2019
  • Chart 24 1: Patent Foramen Ovale Device Market, U.S., 2016 - 2026
  • Chart 24 2: Leading Competitors, Patent Foramen Ovale Device Market, U.S., 2019
  • Chart 25 1: Patent Ductus Arteriosus Closure Device Market, U.S., 2016 - 2026
  • Chart 25 2: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, U.S., 2019
  • Chart 26 1: Atrial & Ventricular Septal Defect Device Market by Segment, U.S., 2016 - 2026
  • Chart 26 2: Atrial & Ventricular Septal Defect Device Market Breakdown, U.S., 2019
  • Chart 26 3: Atrial & Ventricular Septal Defect Device Market Breakdown, U.S., 2026
  • Chart 26 4: Total Atrial & Ventricular Septal Defect Device Market, U.S., 2016 - 2026
  • Chart 26 5: Atrial Septal Defect Closure Device Market, U.S., 2016 - 2026
  • Chart 26 6: Ventricular Septal Defect Device Market, U.S., 2016 - 2026
  • Chart 26 7: Leading Competitors, Atrial & Ventricular Septal Defect Device Market, U.S., 2019
  • Chart 27 1: Left Atrial Appendage Closure Device Market by Segment, U.S., 2016 - 2026
  • Chart 27 2: Left Atrial Appendage Closure Device Market Breakdown, U.S., 2019
  • Chart 27 3: Left Atrial Appendage Closure Device Market Breakdown, U.S., 2026
  • Chart 27 4: Epicardial Device Market by Segment, U.S., 2016 - 2026
  • Chart 27 5: Epicardial Suture Device Market, U.S., 2016 - 2026
  • Chart 27 6: Epicardial Clip Device Market by Segment, U.S., 2016 - 2026
  • Chart 27 7: Open Epicardial Clip Device Market, U.S., 2016 - 2026
  • Chart 27 8: MIS Epicardial Clip Device Market, U.S., 2016 - 2026
  • Chart 27 9: Endocardial Device Market, U.S., 2016 - 2026
  • Chart 27 10: Leading Competitors, Left Atrial Appendage Closure Device Market, U.S., 2019
  • Chart 28 1: Preshaped Guidewire Market, U.S., 2016 - 2026
  • Chart 28 2: Leading Competitors, Preshaped Guidewire Market, U.S., 2019
  • Chart 29 1: Extracorporeal Membrane Oxygenation Machine Market, U.S., 2016 - 2026

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery and Heart Valve Device Market Share Ranking by Segment, U.S., 2019 (1 of 4)
  • Figure 1 2: Cardiac Surgery and Heart Valve Device Market Share Ranking by Segment, U.S., 2019 (2 of 4)
  • Figure 1 3: Cardiac Surgery and Heart Valve Device Market Share Ranking by Segment, U.S., 2019 (3 of 4)
  • Figure 1 4: Cardiac Surgery and Heart Valve Device Market Share Ranking by Segment, U.S., 2019 (4 of 4)
  • Figure 1 5: Companies Researched in this Report
  • Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Device Market by Segment, U.S. (1 of 5)
  • Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Device Market by Segment, U.S. (2 of 5)
  • Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Device Market by Segment, U.S. (3 of 5)
  • Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Device Market by Segment, U.S. (4 of 5)
  • Figure 1 10: Factors Impacting the Cardiac Surgery and Heart Valve Device Market by Segment, U.S. (5 of 5)
  • Figure 1 11: Recent Events in the Cardiac Surgery and Heart Valve Device Market, U.S., 2017 - 2020
  • Figure 1 12: Cardiac Surgery and Heart Valve Procedures Covered, U.S. (1 of 4)
  • Figure 1 13: Cardiac Surgery and Heart Valve Procedures Covered, U.S. (2 of 4)
  • Figure 1 14: Cardiac Surgery and Heart Valve Procedures Covered, U.S., 2019 (3 of 4)
  • Figure 1 15: Cardiac Surgery and Heart Valve Procedures Covered, U.S. (4 of 4)
  • Figure 1 16: Procedure Codes Investigated
  • Figure 1 17: Cardiac Surgery and Heart Valve Device Market Covered, U.S. (1 of 4)
  • Figure 1 18: Cardiac Surgery and Heart Valve Device Market Covered, U.S. (2 of 4)
  • Figure 1 19: Cardiac Surgery and Heart Valve Device Market Covered, U.S. (3 of 4)
  • Figure 1 20: Cardiac Surgery and Heart Valve Device Market Covered, U.S. (4 of 4)
  • Figure 1 21: Key Report Updates
  • Figure 1 22: Version History
  • Figure 3 1: Tissue Heart Valve Devices by Company
  • Figure 3 2: Mechanical Heart Valve Devices by Company
  • Figure 3 3: Annuloplasty Repair Devices by Company
  • Figure 3 4: Transcatheter Mitral Valve Repair Devices by Company
  • Figure 3 5: Transcatheter Heart Valve Replacement Devices by Company
  • Figure 3 6: Cerebral Embolic Protection Devices by Company
  • Figure 3 7: Balloon Valvuloplasty Devices by Company
  • Figure 3 8: On-Pump Coronary Artery Bypass Devices by Company
  • Figure 3 9: Off-Pump Coronary Artery Bypass Devices by Company
  • Figure 3 10: Autotransfusion Devices by Company
  • Figure 3 11: Endoscopic Vessel Harvesting Devices by Company
  • Figure 3 12: Anastomosis Assist Devices by Company
  • Figure 3 13: Transmyocardial Revascularization Devices by Company
  • Figure 3 14: Ventricular Assist Devices by Company
  • Figure 3 15: Intra-Aortic Balloon Pump Devices by Company
  • Figure 3 16: Artificial Heart Replacement Devices by Company
  • Figure 3 17: Remote Hemodynamic Monitoring System Devices by Company
  • Figure 3 18: Patent Foramen Ovale Devices by Company
  • Figure 3 19: Patent Ductus Arteriosus Closure Devices by Company
  • Figure 3 20: Atrial & Ventricular Septal Defect Devices by Company
  • Figure 3 21: Left Atrial Appendage Closure Devices by Company
  • Figure 3 22: Preshaped Guidewires by Company
  • Figure 3 23: Class 2 Device Recall, Abbott
  • Figure 3 24: Class 2 Device Recall, Abbott
  • Figure 3 25: Class 2 Device Recall, Cardica
  • Figure 3 26: Class 2 Device Recall, Cook Medical
  • Figure 3 27: Class 1 Device Recall, CryoLife
  • Figure 3 28: Class 2 Device Recall, CryoLife
  • Figure 3 29: Class 1 Device Recall, Edwards LifeSciences
  • Figure 3 30: Class 2 Device Recall, Edwards LifeSciences
  • Figure 3 31: Class 2 Device Recall, Getinge
  • Figure 3 32: Class 1 Device Recall, Getinge
  • Figure 3 33: Class 1 Device Recall, Getinge
  • Figure 3 34: Class 1 Device Recall, Getinge
  • Figure 3 35: Class 2 Device Recall, Haemonetics
  • Figure 3 36: Class 3 Device Recall, LivaNova
  • Figure 3 37: Class 2 Device Recall, LivaNova
  • Figure 3 38: Class 2 Device Recall, LivaNova
  • Figure 3 39: Class 2 Device Recall, Medtronic
  • Figure 3 40: Class 1 Device Recall, Medtronic
  • Figure 3 41: Class 1 Device Recall, Medtronic
  • Figure 3 42: Class 1 Device Recall, Medtronic
  • Figure 3 43: Class 1 Device Recall, Medtronic
  • Figure 3 44: Class 1 Device Recall, Teleflex
  • Figure 3 45: Class 1 Device Recall, Teleflex
  • Figure 3 46: Class 1 Device Recall, Terumo
  • Figure 3 47: Class 2 Device Recall, Terumo
  • Figure 3 48: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
  • Figure 3 49: The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices
  • Figure 3 50: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR)
  • Figure 3 51: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR)
  • Figure 3 52: Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
  • Figure 3 53: Mitral Annuloplasty Rings RCT
  • Figure 3 54: Aortic Valve Replacement Above the Aortic Annulus (SA-AVR) With the Carpentier-Edwards Magna-Ease Bioprosthesis (SA-AVR)
  • Figure 3 55: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT)
  • Figure 3 56: COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients with Pulmonary Valve Dysfunction
  • Figure 3 57: PARTNER 3 Trial - Mitral Valve in Valve
  • Figure 3 58: PRESERVE-MITRAL Post-Market Registry
  • Figure 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, Best Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 3)
  • Figure 4 2: Cardiac Surgery and Heart Valve Device Market by Segment, Best Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 3)
  • Figure 4 3: Cardiac Surgery and Heart Valve Device Market by Segment, Best Case Scenario, U.S., 2016 - 2026 (US$M) (3 of 3)
  • Figure 4 4: Cardiac Surgery and Heart Valve Device Market by Segment, Base Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 3)
  • Figure 4 5: Cardiac Surgery and Heart Valve Device Market by Segment, Base Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 3)
  • Figure 4 6: Cardiac Surgery and Heart Valve Device Market by Segment, Base Case Scenario, U.S., 2016 - 2026 (US$M) (3 of 3)
  • Figure 4 7: Cardiac Surgery and Heart Valve Device Market by Segment, Worst Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 3)
  • Figure 4 8: Cardiac Surgery and Heart Valve Device Market by Segment, Worst Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 3)
  • Figure 4 9: Cardiac Surgery and Heart Valve Device Market by Segment, Worst Case Scenario, U.S., 2016 - 2026 (US$M) (3 of 3)
  • Figure 5 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (1 of 3)
  • Figure 5 2: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (2 of 3)
  • Figure 5 3: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (3 of 3)
  • Figure 5 4: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2016 - 2026 (1 of 3)
  • Figure 5 5: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2016 - 2026 (2 of 3)
  • Figure 5 6: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2016 - 2026 (3 of 3)
  • Figure 5 7: Drivers and Limiters, Cardiac Surgery and Heart Valve Device Market, U.S., 2019
  • Figure 5 8: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (1 of 3)
  • Figure 5 9: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (2 of 3)
  • Figure 5 10: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2016 - 2026 (US$M) (3 of 3)
  • Figure 5 11: SWOT Analysis, Abbott
  • Figure 5 12: SWOT Analysis, Abiomed
  • Figure 5 13: SWOT Analysis, AtriCure
  • Figure 5 14: SWOT Analysis, Boston Scientific
  • Figure 5 15: SWOT Analysis, CryoLife
  • Figure 5 16: SWOT Analysis, Edwards LifeSciences
  • Figure 5 17: SWOT Analysis, LivaNova
  • Figure 5 18: SWOT Analysis, Getinge
  • Figure 5 19: SWOT Analysis, Medtronic
  • Figure 5 20: SWOT Analysis, Teleflex
  • Figure 5 21: SWOT Analysis, Terumo
  • Figure 6 1: Procedure Codes Investigated, U.S.
  • Figure 6 2: Cardiac Surgery and Heart Valve Procedures, U.S., 2016 - 2026 (1 of 3)
  • Figure 6 3: Cardiac Surgery and Heart Valve Procedures, U.S., 2016 - 2026 (2 of 3)
  • Figure 6 4: Cardiac Surgery and Heart Valve Procedures, U.S., 2016 - 2026 (3 of 3)
  • Figure 6 5: Surgical Heart Valve Replacement Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 6: Tissue Heart Valve Procedures by Valve Type, U.S., 2016 - 2026
  • Figure 6 7: Tissue Heart Valve Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 8: Tissue Heart Valve Procedures by Tissue Type, U.S., 2016 - 2026
  • Figure 6 9: Mechanical Heart Valve Procedures by Valve Type, U.S., 2016 - 2026
  • Figure 6 10: Mechanical Heart Valve Replacement Procedures by Tissue Type, U.S., 2016 - 2026
  • Figure 6 11: Annuloplasty Repair Procedures by Valve Type, U.S., 2016 - 2026
  • Figure 6 12: Annuloplasty Repair Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 13: Transcatheter Mitral Valve Repair Procedures by Approach, U.S., 2016 - 2026
  • Figure 6 14: Transcatheter Mitral Valve Repair Procedures by Disease, U.S., 2016 - 2026
  • Figure 6 15: Transcatheter Heart Valve Replacement Procedures by Valve Type, U.S., 2016 - 2026
  • Figure 6 16: Transcatheter Aortic Heart Valve Replacement Procedures by Approach, U.S., 2016 - 2026
  • Figure 6 17: Transcatheter Aortic Heart Valve Replacement Procedures by Patient Risk Class, U.S., 2016 - 2026
  • Figure 6 18: Transcatheter Aortic Valve Replacement Procedures by Embolic Protection, U.S., 2016 - 2026
  • Figure 6 19: Transcatheter Aortic Heart Valve Replacement Procedures by Therapy, U.S., 2016 - 2026
  • Figure 6 20: Transcatheter Aortic Heart Valve Replacement Procedures by Location, U.S., 2016 - 2026
  • Figure 6 21: Balloon Valvuloplasty Procedures, U.S., 2016 - 2026
  • Figure 6 22: CABG Procedures by Support Type, U.S., 2016 - 2026
  • Figure 6 23: 6.7.2 CABG Vessel Harvesting Procedures by Type, U.S., 2016 - 2026
  • Figure 6 24: CABG Procedures by Suture Type, U.S., 2016 - 2026
  • Figure 6 25: CABG Procedures by Approach, U.S., 2016 - 2026 (1 of 2)
  • Figure 6 26: CABG Procedures by Approach, U.S., 2016 - 2026 (2 of 2)
  • Figure 6 27: Transmyocardial Revascularization Procedures, U.S., 2016 - 2026
  • Figure 6 28: Ventricular Assist Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 29: Percutaneous Ventricular Assist Procedures by Heart Side, U.S., 2016 - 2026
  • Figure 6 30: Percutaneous Ventricular Assist Procedures by Indication, U.S., 2016 - 2026
  • Figure 6 31: Implantable Ventricular Assist Procedures by Indication, U.S., 2016 - 2026
  • Figure 6 32: Implantable Ventricular Assist Procedures by Area, U.S., 2016 - 2026
  • Figure 6 33: External Ventricular Assist Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 34: Intra-Aortic Balloon Counterpulsation Procedures by Setting, U.S., 2016 - 2026
  • Figure 6 35: Intra-Aortic Balloon Pump Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 36: Heart Transplant Procedures by Type, U.S., 2016 - 2026
  • Figure 6 37: Remote Hemodynamic Monitoring Device Implantation Procedures, U.S., 2016 - 2026
  • Figure 6 38: Patent Foramen Ovale Closure Procedures, U.S., 2016 - 2026
  • Figure 6 39: Patent Ductus Arteriosus Closure Procedures, U.S., 2016 - 2026
  • Figure 6 40: Septal Defect Closure Procedures by Anatomy, U.S., 2016 - 2026
  • Figure 6 41: Left Atrial Appendage Closure Procedures by Type, U.S., 2016 - 2026
  • Figure 6 42: Epicardial Device Procedures by Device Type, U.S., 2016 - 2026
  • Figure 6 43: Epicardial Clip Device Procedures by Approach, U.S., 2016 - 2026
  • Figure 7 1: Tissue Heart Valve Market by Device Type, U.S., 2016 - 2026 (US$M)
  • Figure 7 2: Tissue Heart Valve Market by Tissue Type, U.S., 2016 - 2026 (US$M)
  • Figure 7 3: Total Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 4: Stented Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 5: Sutureless/Rapid Deployment Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 6: Stentless Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 7: Xenograft Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 8: Allograft Tissue Heart Valve Market, U.S., 2016 - 2026
  • Figure 7 9: Drivers and Limiters, Tissue Heart Valve Market, U.S., 2019
  • Figure 7 10: Leading Competitors, Tissue Heart Valve Market, U.S., 2019
  • Figure 8 1: Mechanical Heart Valve Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 8 2: Total Mechanical Heart Valve Market, U.S., 2016 - 2026
  • Figure 8 3: Mechanical Heart Valve without Conduit Market, U.S., 2016 - 2026
  • Figure 8 4: Mechanical Heart Valve with Conduit Market, U.S., 2016 - 2026
  • Figure 8 5: Drivers and Limiters, Mechanical Heart Valve Market, U.S., 2019
  • Figure 8 6: Leading Competitors, Mechanical Heart Valve Market, U.S., 2019
  • Figure 9 1: Annuloplasty Repair Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 9 2: Total Annuloplasty Repair Device Market, U.S., 2016 - 2026
  • Figure 9 3: Ring Device Market, U.S., 2016 - 2026
  • Figure 9 4: Band Device Market, U.S., 2016 - 2026
  • Figure 9 5: Drivers and Limiters, Annuloplasty Repair Device Market, U.S., 2019
  • Figure 9 6: Leading Competitors, Annuloplasty Repair Device Market, U.S., 2019
  • Figure 10 1: Transcatheter Mitral Valve Repair Device Market, U.S., 2016 - 2026
  • Figure 10 2: Drivers and Limiters, Transcatheter Mitral Valve Repair Device Market, U.S., 2019
  • Figure 10 3: Leading Competitors, Transcatheter Mitral Valve Repair Device Market, U.S., 2019
  • Figure 11 1: Transcatheter Heart Valve Replacement Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 11 2: Total Transcatheter Heart Valve Replacement Device Market, U.S., 2016 - 2026
  • Figure 11 3: Transcatheter Aortic Valve Replacement Device Market, U.S., 2016 - 2026
  • Figure 11 4: Transcatheter Pulmonary Valve Replacement Device Market, U.S., 2016 - 2026
  • Figure 11 5: Drivers and Limiters, Transcatheter Heart Valve Replacement Device Market, U.S., 2019
  • Figure 11 6: Leading Competitors, Transcatheter Heart Valve Replacement Device Market, U.S., 2019
  • Figure 12 1: Cerebral Embolic Protection Device Market, U.S., 2016 - 2026
  • Figure 12 2: Drivers and Limiters, Cerebral Embolic Protection Device Market, U.S., 2019
  • Figure 12 3: Leading Competitors, Cerebral Embolic Protection Device Market, U.S., 2019
  • Figure 13 1: Balloon Valvuloplasty Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 13 2: Total Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Figure 13 3: Aortic Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Figure 13 4: Mitral Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Figure 13 5: Pulmonary Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Figure 13 6: Hybrid Balloon Valvuloplasty Market, U.S., 2016 - 2026
  • Figure 13 7: Drivers and Limiters, Balloon Valvuloplasty Market, U.S., 2019
  • Figure 13 8: Leading Competitors, Balloon Valvuloplasty Market, U.S., 2019
  • Figure 14 1: On-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 14 2: ONCAB Disposables Market, U.S., 2016 - 2026
  • Figure 14 3: Perfusion System Market, U.S., 2016 - 2026
  • Figure 14 4: Drivers and Limiters, On-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Figure 14 5: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Figure 15 1: Off-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 15 2: Stabilizer Device Market, U.S., 2016 - 2026
  • Figure 15 3: Positioner Device Market, U.S., 2016 - 2026
  • Figure 15 4: OPCAB Accessories Market by Segment, U.S., 2016 - 2026
  • Figure 15 5: Blower/Mister Market, U.S., 2016 - 2026
  • Figure 15 6: Intracoronary Shunt Market, U.S., 2016 - 2026
  • Figure 15 7: Drivers and Limiters, Off-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Figure 15 8: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, U.S., 2019
  • Figure 16 1: Autotransfusion Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 16 2: Autotransfusion Machine Market, U.S., 2016 - 2026
  • Figure 16 3: Autotransfusion Machine Install Base by Agreement, U.S., 2016 - 2026
  • Figure 16 4: Autotransfusion Disposables Market, U.S., 2016 - 2026
  • Figure 16 5: Drivers and Limiters, Autotransfusion Device Market, U.S., 2019
  • Figure 16 6: Leading Competitors, Autotransfusion Device Market, U.S., 2019
  • Figure 17 1: Endoscopic Vessel Harvesting Device Market, U.S., 2016 - 2026
  • Figure 17 2: Drivers and Limiters, Endoscopic Vessel Harvesting Device Market, U.S., 2019
  • Figure 17 3: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2019
  • Figure 18 1: Anastomosis Assist Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 18 2: Total Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Figure 18 3: Proximal Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Figure 18 4: Distal Anastomosis Assist Device Market, U.S., 2016 - 2026
  • Figure 18 5: Drivers and Limiters, Anastomosis Assist Device Market, U.S., 2019
  • Figure 18 6: Leading Competitors, Anastomosis Assist Device Market, U.S., 2019
  • Figure 19 1: Transmyocardial Revascularization Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 19 2: Single-Use Fiber-Optic Handpiece Market, U.S., 2016 - 2026
  • Figure 19 3: TMR Laser Console Market by Segment, U.S., 2016 - 2026
  • Figure 19 4: TMR Laser Console Device Market, U.S., 2016 - 2026
  • Figure 19 5: TMR Laser Console Service Market, U.S., 2016 - 2026
  • Figure 19 6: Drivers and Limiters, Transmyocardial Revascularization Device Market, U.S., 2019
  • Figure 19 7: Leading Competitors, Transmyocardial Revascularization Device Market, U.S., 2019
  • Figure 20 1: Ventricular Assist Device Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 20 2: Total Ventricular Assist Device Market, U.S., 2016 - 2026
  • Figure 20 3: Percutaneous VAD Market by Segment, U.S., 2016 - 2026
  • Figure 20 4: Left Heart pVAD Market, U.S., 2016 - 2026
  • Figure 20 5: Right Heart pVAD Market, U.S., 2016 - 2026
  • Figure 20 6: Implantable VAD Market, U.S., 2016 - 2026
  • Figure 20 7: External VAD Market by Segment, U.S., 2016 - 2026
  • Figure 20 8: Short-Term External VAD Market, U.S., 2016 - 2026
  • Figure 20 9: Long-Term External VAD Market, U.S., 2016 - 2026
  • Figure 20 10: Implantable VAD Market Units by Indication, U.S., 2016 - 2026
  • Figure 20 11: Drivers and Limiters, Ventricular Assist Device Market, U.S., 2019
  • Figure 20 12: Leading Competitors, Ventricular Assist Device Market, U.S., 2019
  • Figure 21 1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2016 - 2026 (US$M)
  • Figure 21 2: Intra-Aortic Balloon (IABP) Catheter Market by Segment, U.S., 2016 - 2026
  • Figure 21 3: Conventional Intra-Aortic Balloon (IABP) Catheter Market, U.S., 2016 - 2026
  • Figure 21 4: Fiber-Optic Intra-Aortic Balloon (IABP) Catheter Market, U.S., 2016 - 2026
  • Figure 21 5: Intra-Aortic Balloon Pump (IABP) Console Market, U.S., 2016 - 2026
  • Figure 21 6: Drivers and Limiters, Intra-Aortic Balloon Pump Market, U.S., 2019
  • Figure 21 7: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2019
  • Figure 22 1: Artificial Heart Replacement Device Market, U.S., 2016 - 2026
  • Figure 22 2: Drivers and Limiters, Artificial Heart Replacement Device Market, U.S., 2019
  • Figure 22 3: Leading Competitors, Artificial Heart Replacement Device Market, U.S., 2019
  • Figure 23 1: Remote Hemodynamic Monitoring System Market, U.S., 2016 - 2026
  • Figure 23 2: Drivers and Limiters, Remote Hemodynamic Monitoring System Market, U.S., 2019
目次
Product Code: iDATA_USCS20_MS

Throughout this medical market research, iData Research analyzed 43 cardiac surgery companies companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the US Cardiac Surgery Device and Heart Valve Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered

  • 1. Procedure Volumes for the US Cardiac Surgery Market - MedPro
  • 2. Tissue Heart Valve Market - MedCore
  • 3. Mechanical Heart Valve Market - MedCore
  • 4. Annuloplasty Repair Device Market - MedCore
  • 5. Transcatheter Mitral Valve Repair Device Market - MedCore
  • 6. Transcatheter Heart Valve Replacement Market - MedCore
  • 7. Cerebral Embolic Protection Device Market - MedCore
  • 8. Balloon Valvuloplasty Market - MedCore
  • 9. On-Pump Coronary Artery Bypass Device Market - MedCore
  • 10. Off-Pump Coronary Artery Bypass Device Market - MedCore
  • 11. Autotransfusion Device Market - MedCore
  • 12. Endoscopic Vessel Harvesting Device Market - MedCore
  • 13. Anastomosis Assist Device (AAD) Market - MedCore
  • 14. Transmyocardial Revascularization Market - MedCore
  • 15. Ventricular Assist Device (VAD) Market - MedCore
  • 16. Intra-Aortic Balloon Pump Market - MedCore
  • 17. Artificial Heart Replacement Device Market - MedCore
  • 18. Remote Hemodynamic Monitoring System Market - MedCore
  • 19. Patent Foramen Ovale Closure Device Market - MedCore
  • 20. Patent Ductus Arteriosus Closure Device Market - MedCore
  • 21. Atrial Septal & Ventricular Septal Defect Closure Device Marke - MedCore
  • 22. Left Atrial Appendage Closure Device Market - MedCore
  • 23. Preshaped Guidewire Market - MedCore
  • 24. Extracorporeal Membrane Oxygenation Market - MedCore

US Cardiac Surgery Device Market Insights

A major limiter to the cardiac surgery market is the limited clinical data available for some of the newer markets. Growth in the cerebral embolic protection (CEPD) market may be limited until a large randomized clinical trial is conducted to determine the device's exact role in reducing cerebral ischemic volumes. The CEPD market has experienced strong growth in recent years but may be unable to reach its full market potential without this additional clinical data.

A major driver in the cardiac surgery market is the patient population, which is large for many of the indications for cardiac surgery devices. Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves. This condition is typically present in patients who have several other co-morbidities, making them poor candidates for open, invasive surgery.

Overall, the U.S. cardiac surgery and heart valve device market was valued at $7.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 7.7% to reach $12.1 billion.

The full report suite on the U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair devices, transcatheter heart valve replacement devices, cerebral embolic protection devices, balloon valvuloplasty, on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, transmyocardial revascularization devices, ventricular assist devices, intra-aortic balloon pumps, artificial heart replacement devices, remote hemodynamic monitoring systems, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial septal defect devices, ventricular septal defect devices, left atrial appendage closure devices and preshaped guidewires. Analysis of the U.S. market for extracorporeal membrane oxygenation devices is included as an appendix.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1 Coronary Artery Disease
    • 2.2.2 Myocardial Infarction
    • 2.2.3 Angina Pectoris
    • 2.2.4 Heart Valve Disease
    • 2.2.5 Congestive Heart Failure
    • 2.2.6 Aortic Stenosis
    • 2.2.7 Degenerative/Functional Mitral Regurgitation
  • 2.3 PATIENT DEMOGRAPHICS
    • 2.3.1 General Statistics

PRODUCT ASSESSMENT

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • 3.2.1 Tissue Heart Valve Device
    • 3.2.2 Mechanical Heart Valve Device
    • 3.2.3 Annuloplasty Repair Device
    • 3.2.4 Transcatheter Mitral Valve Repair Device
    • 3.2.5 Transcatheter Heart Valve Replacement Device
    • 3.2.6 Cerebral Embolic Protection Device
    • 3.2.7 Balloon Valvuloplasty Device
    • 3.2.8 On-Pump Coronary Artery Bypass Device
    • 3.2.9 Off-Pump Coronary Artery Bypass Device
    • 3.2.10 Autotransfusion Device
    • 3.2.11 Endoscopic Vessel Harvesting Device
    • 3.2.12 Anastomosis Assist Device
    • 3.2.13 Transmyocardial Revascularization Device
    • 3.2.14 Ventricular Assist Device
    • 3.2.15 Intra-Aortic Balloon Pump Device
    • 3.2.16 Artificial Heart Replacement Device
    • 3.2.17 Remote Hemodynamic Monitoring System Device
    • 3.2.18 Patent Foramen Ovale Device
    • 3.2.19 Patent Ductus Arteriosus Closure Device
    • 3.2.20 Atrial & Ventricular Septal Defect Device
    • 3.2.21 Left Atrial Appendage Closure Device
    • 3.2.22 Preshaped Guidewires
  • 3.3 REGULATORY ISSUES AND RECALLS
  • 3.4 CLINICAL TRIALS
    • 3.4.1 Abbott
    • 3.4.2 CryoLife
    • 3.4.3 Edwards LifeSciences
    • 3.4.4 Medtronic

IMPACT OF COVID-19 ON U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET

  • 4.1 INTRODUCTION
  • 4.2 MULTI-SCENARIO ANALYSIS
      • 4.2.1.1 Best Case Scenario
      • 4.2.1.2 Base Case Scenario
      • 4.2.1.3 Worst Case Scenario

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET OVERVIEW
  • 5.3 TREND ANALYSIS BY SEGMENT
  • 5.4 DRIVERS AND LIMITERS
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 COMPETITIVE MARKET SHARE ANALYSIS
  • 5.6 MERGERS AND ACQUISITIONS
  • 5.7 COMPANY PROFILES
    • 5.7.1 Abbott
    • 5.7.2 Abiomed
    • 5.7.3 AtriCure
    • 5.7.4 Boston Scientific
    • 5.7.5 CryoLife
    • 5.7.6 Edwards LifeSciences
    • 5.7.7 LivaNova
    • 5.7.8 Getinge
    • 5.7.9 Medtronic
    • 5.7.10 Teleflex
    • 5.7.11 Terumo
  • 5.8 SWOT ANALYSIS
    • 5.8.1 Abbott
    • 5.8.2 Abiomed
    • 5.8.3 AtriCure
    • 5.8.4 Boston Scientific
    • 5.8.5 CryoLife
    • 5.8.7 Edwards LifeSciences
    • 5.8.8 LivaNova
    • 5.8.10 Getinge
    • 5.8.11 Medtronic
    • 5.8.12 Teleflex
    • 5.8.13 Terumo

PROCEDURE NUMBERS

  • 6.1 INTRODUCTION
  • 6.2 CARDIAC SURGERY AND HEART VALVE PROCEDURES
  • 6.3 SURGICAL HEART VALVE REPLACEMENT PROCEDURES
    • 6.3.1 Tissue Heart Valve Procedures by Valve Type
    • 6.3.2 Tissue Heart Valve Procedures by Device Type
    • 6.3.3 Tissue Heart Valve Procedures by Tissue Type
    • 6.3.4 Mechanical Heart Valve Replacement Procedures by Valve Type
    • 6.3.5 Mechanical Heart Valve Replacement Procedures by Tissue Type
  • 6.4 ANNULOPLASTY REPAIR PROCEDURES
    • 6.4.1 Annuloplasty Repair Procedures by Valve Type
    • 6.4.2 Annuloplasty Repair Procedures by Device Type
  • 6.5 TRANSCATHETER MITRAL VALVE REPAIR PROCEDURES
    • 6.5.1 Transcatheter Mitral Valve Procedures by Approach
    • 6.5.2 Transcatheter Mitral Valve Repair Procedures by Disease
  • 6.6 TRANSCATHETER HEART VALVE REPLACEMENT PROCEDURES
    • 6.6.1 Transcatheter Heart Valve Replacement Procedures by Valve Type
      • 6.6.1.1 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Approach
      • 6.6.1.2 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Patient Risk Class
      • 6.6.1.3 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Embolic Protection
      • 6.6.1.4 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Therapy
      • 6.6.1.5 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Location
  • 6.7 BALLOON VALVULOPLASTY PROCEDURES
  • 6.8 CABG PROCEDURES
    • 6.8.1 CABG Procedures by Support Type
    • 6.8.2 CABG Vessel Harvesting Procedures by Type
    • 6.8.3 CABG Procedures by Suture Type
    • 6.8.4 CABG Procedures by Approach
  • 6.9 TRANSMYOCARDIAL REVASCULARIZATION PROCEDURES
  • 6.10 VENTRICULAR ASSIST DEVICE PROCEDURES
    • 6.10.1 Ventricular Assist Procedures by Device Type
      • 6.10.1.1 Percutaneous Ventricular Assist Procedures by Heart Side
      • 6.10.1.2 Percutaneous Ventricular Assist Procedures by Indication
      • 6.10.1.3 Implantable Ventricular Assist Procedures by Indication
      • 6.10.1.4 Implantable Ventricular Assist Procedures by Area
      • 6.10.1.5 External Ventricular Assist Procedures by Device Type
  • 6.11 INTRA-AORTIC BALLOON COUNTERPULSATION PROCEDURES
    • 6.11.1 Intra-Aortic Balloon Counterpulsation Procedures by Setting
    • 6.11.2 Intra-Aortic Balloon Counterpulsation Procedures by Device Type
  • 6.12 HEART TRANSPLANT PROCEDURES
  • 6.13 REMOTE HEMODYNAMIC MONITORING DEVICE IMPLANTATION PROCEDURES
  • 6.14 PATENT FORAMEN OVALE CLOSURE PROCEDURES
  • 6.15 PATENT DUCTUS ARTERIOSUS CLOSURE PROCEDURES
  • 6.16 SEPTAL DEFECT CLOSURE PROCEDURES
    • 6.16.1 Septal Defect Closure Procedures by Anatomy
  • 6.17 LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES
    • 6.17.1 Left Atrial Appendage Closure Procedures by Type
      • 6.17.1.1 Epicardial Device Procedures by Device Type
      • 6.17.1.1.1 Epicardial Clip Device Procedures by Approach

TISSUE HEART VALVE MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET OVERVIEW
    • 7.2.1 Tissue Heart Valve Market by Device Type
    • 7.2.2 Tissue Heart Valve Market by Tissue Type
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Total Tissue Heart Valve Market
    • 7.3.2 Tissue Heart Valve Market by Device Type
      • 7.3.2.1 Stented Tissue Heart Valve Market
      • 7.3.2.2 Sutureless/Rapid Deployment Tissue Heart Valve Market
      • 7.3.2.3 Stentless Tissue Heart Valve Market
    • 7.3.3 Tissue Heart Valve Market by Tissue Type
      • 7.3.3.1 Xenograft Tissue Heart Valve Market
      • 7.3.3.2 Allograft Tissue Heart Valve Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS

MECHANICAL HEART VALVE MARKET

  • 8.1 INTRODUCTION
  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST
    • 8.3.1 Total Mechanical Heart Valve Market
    • 8.3.2 Mechanical Heart Valve without Conduit Market
    • 8.3.3 Mechanical Heart Valve with Conduit Market
  • 8.4 DRIVERS AND LIMITERS
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS

ANNULOPLASTY REPAIR DEVICE MARKET

  • 9.1 INTRODUCTION
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1 Total Annuloplasty Repair Device Market
    • 9.3.2 Ring Device Market
    • 9.3.3 Band Device Market
  • 9.4 DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET

  • 10.1 INTRODUCTION
  • 10.2 MARKET ANALYSIS AND FORECAST
  • 10.3 DRIVERS AND LIMITERS
    • 10.3.1 Market Drivers
    • 10.3.2 Market Limiters
  • 10.4 COMPETITIVE MARKET SHARE ANALYSIS
    • 10.4.1 Potential Competitors

TRANSCATHETER HEART VALVE REPLACEMENT DEVICE MARKET

  • 11.1 INTRODUCTION
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 Total Transcatheter Heart Valve Replacement Device Market
    • 11.3.2 Transcatheter Aortic Valve Replacement Device Market
    • 11.3.3 Transcatheter Pulmonary Valve Replacement Device Market
  • 11.4 DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS
    • 11.5.1 Potential Competitors

CEREBRAL EMBOLIC PROTECTION DEVICE MARKET

  • 12.1 INTRODUCTION
  • 12.2 MARKET ANALYSIS AND FORECAST
  • 12.3 DRIVERS AND LIMITERS
    • 12.3.1 Market Drivers
    • 12.3.2 Market Limiters
  • 12.4 COMPETITIVE MARKET SHARE ANALYSIS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.